Synchron Company
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Estimated Revenue:
$50M to $100M
Funding Status:
Late Stage Venture
Industry:
Med Tech
Investors Number:
23.0
Last Funding Date:
2022-12-15
Number Of Exists:
Series A
Technology:
['BioTech & HealthTech']
Founded Date:
2016-04-01
Investor Type:
Company
Headquarters:
Brooklyn, New York, United States
Total Funding:
130000000.0
Last Funding Type:
Series C
Employee Number:
1-10
Investment Stage:
N/A